SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has ...
Moleculin Biotech (NASDAQ:MBRX) is offering 16.08M shares or pre-funded warrants and Series E warrants to purchase up to 48.24M shares at $0.37/unit. Series E warrants have a $0.37 exercise price, are ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Evaxion ...
SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed its ...